Sign in

CIK 0001746466

  • Non-accelerated filer
  • Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821554746
Phone
+1 858-412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $4.52 ($113,045)
  6. 4 Open-market sale Chief Financial Officer sold 8,000 shares at $4.74 ($37,914)
  7. 4 Other acquisition Chief Financial Officer acquired 5,362 shares (other)
  8. 4 Other acquisition Sr. Vice President and COO acquired 1,097 shares (other)
  9. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $5.62 ($140,395)
  10. 4 Open-market sale Chief Scientific Officer sold 250,000 shares at $8.13 ($2,033,475)
  11. 4 Other acquisition Chief Financial Officer acquired 5,014 shares (other)
  12. 4 Other acquisition Sr. Vice President and COO acquired 9,570 shares (other)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 9 · 177 filings